Abstract:Rheumatoid Arthritis (RA) stands as an intricate autoimmune inflammatory ailment, inciting joint inflammation and emerging as the most prevalent variant of inflammatory arthritis, impacting approximately 0.5% to 1% of the global populace. [ 1 , 2 ] Its occurrence registers 2 to 3 times higher among women in comparison to men. [ 3 ] Familial factors contribute to the condition in 40% to 65% of seropositive patients and 20% of seronegative patients. [ 4 ] The 2010 edition of RA diagnostic criteria comprises 4 facets: joint engagement, serological anomalies ascertained through RFs and ACPAs assessments, heightened indicators of acute inflammatory response, and arthritis duration. [ 5 ] Notably, RF measurements usually yield negative results in early RA. [ 6 ] Similarly, the ACPAs test exhibits low sensitivity in RA diagnosis. [ 7 ] Consequently, the novel RA classification criteria exhibit their imperfections as well, underscoring the significance of identifying novel serological biomarkers with substantial clinical utility to enhance RA diagnosis. In terms of treatment, non-steroidal anti-inflammatory drugs, glucocorticoids, and disease-modifying anti-rheumatic drugs represent commonplace interventions for RA. However, they often accompany side effects and demonstrate limited efficacy. [ 8 , 9 ] Although the precise etiology of RA remains elusive, it is generally attributed to a blend of epigenetic alterations, immune dysregulation, and environmental influences. [ 10 ] DNA methylation emerges as the quintessential epigenetic modification in humans, intimately linked with immune dysregulation. [ 11–13 ] Furthermore, RA-related DNA methylation patterns exhibit site-specific variances linked to immune pathways. [ 14 ] Recognizing the potential reversibility of epigenetic alterations, probing epigenetic malfunctions in autoimmune disorders has the capacity to uncover novel biomarkers and innovative therapeutic targets. Bibliometric analysis, a systematic and quantitative technique for scrutinizing scientific literature, assumes a pivotal role in research endeavors. It expedites the comprehension of epigenetic trends within rheumatoid arthritis, facilitating the identification of eminent authors and prolific research institutions, while swiftly pinpointing high-confidence, compelling research areas. [ 15 ] Herein, we undertake a visual analysis and synthesis of DNA methylation trends in rheumatoid arthritis, offering insights into the role of DNA methylation in the mechanisms, diagnostics, and treatments of this condition.

Geo-epidemiology of autoantibodies in rheumatoid arthritis: comparison between four ethnically diverse populations

The HLA‐DRB1 Shared Epitope is Not Associated with Antibodies Against Cyclic Citrullinated Peptide in Chinese Patients with Rheumatoid Arthritis

Global epidemiology of rheumatoid arthritis

Identification of circulating autoantibodies to non-modified proteins associated with ACPA status in early rheumatoid arthritis

[A Cross-Sectional Study on the Clinical Phenotypes of Rheumatoid Arthritis].

Antibodies against advanced glycation end-products and malondialdehyde-acetaldehyde adducts identify a new specific subgroup of hitherto patients with seronegative arthritis with a distinct clinical phenotype and an HLA class II association

Association of PADI4 Gene Polymorphisms With Susceptibility to Rheumatoid Arthritis: Evidence From 24 Case–Control Studies

DNA Methylation of the MHC Region in Rheumatoid Arthritis: Perspectives and Challenges

Immune response to post-translationally modified proteins in rheumatoid arthritis: what makes it special?

Genetics, epigenetics and autoimmunity constitute a Bermuda triangle for the pathogenesis of rheumatoid arthritis

Isotypes of autoantibodies against novel differential 4-hydroxy-2-nonenal-modified peptide adducts in serum is associated with rheumatoid arthritis in Taiwanese women

Global research trends in DNA methylation in rheumatoid arthritis: A bibliometric analysis and visual analysis

Antibodies to Porphyromonas gingivalis Indicate Interaction Between Oral Infection, Smoking, and Risk Genes in Rheumatoid Arthritis Etiology

The Contribution of Genetic Variation and Aberrant Methylation of Aryl Hydrocarbon Receptor Signaling Pathway Genes to Rheumatoid Arthritis

Distinct mucosal endotypes as initiators and drivers of rheumatoid arthritis

Role of Selected Genetic Polymorphisms in the Development of Rheumatoid Arthritis in a British White Population

Identifying shared genetic architecture between rheumatoid arthritis and other conditions: a phenome-wide association study with genetic risk scores

Autoantibodies in rheumatoid arthritis – rheumatoid factor, anticitrullinated protein antibodies and beyond

The Impact of Rheumatoid Arthritis on First Nations and How We Can Work With Communities to Prevent It

Association Between Ccr6 and Rheumatoid Arthritis: A Meta-Analysis

Phenome-Wide Association Study of Autoantibodies to Citrullinated and Noncitrullinated Epitopes in Rheumatoid Arthritis